HRP Anti-c-Myc antibody [Y69]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(7 Publications)
Rabbit Recombinant Monoclonal C-Myc/MYC antibody - conjugated to HRP. Suitable for WB and reacts with Human samples. Cited in 7 publications.
View Alternative Names
BHLHE39, MYC, Myc proto-oncogene protein, Class E basic helix-loop-helix protein 39, Proto-oncogene c-Myc, Transcription factor p64, bHLHe39
- WB
Lab
Western blot - HRP Anti-c-Myc antibody [Y69] (AB205818)
This blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 3% milk before being incubated with ab205818 overnight at 4°C. Antibody binding was visualised using ECL development solution ab133406.
All lanes:
Western blot - HRP Anti-c-Myc antibody [Y69] (ab205818) at 1/5000 dilution
Lane 1:
Raji (Human Burkitt's lymphoma cell line) Whole Cell Lysate at 10 µg
Lane 2:
K562 (Human erythromyeloblastoid leukemia cell line) Whole Cell Lysate at 10 µg
Predicted band size: 48 kDa
Observed band size: 58 kDa
true
Exposure time: 4min
Related conjugates and formulations (7)
-
519 FITC
FITC Anti-c-Myc antibody [Y69]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-c-Myc antibody [Y69]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-c-Myc antibody [Y69]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-c-Myc antibody [Y69]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-c-Myc antibody [Y69]
-
Anti-c-Myc antibody [Y69] - ChIP Grade
-
Anti-c-Myc antibody [Y69] - ChIP Grade - BSA and Azide free
Reactivity data
Product details
If you need other conjugated anti-c-myc (Y69) RabMAb antibodies, find our range of products here.
We also offer a PBS only version of this clone as product ab168727.
For more information on choosing the right c-Myc antibody for you, please visit Antibodies to c-Myc and Myc tag.
To support you in your research, we offer a wider range of tools to study c-Myc and Myc-tagged proteins.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
C-Myc is involved in regulating cell growth and proliferation. It forms part of the Myc/Max complex which binds to DNA to regulate gene expression. This activity affects cellular metabolism ribosome biogenesis and cell cycle entry emphasizing its regulation of cellular energy and stress response. Its expression levels critically govern normal cellular functions and homeostasis.
Pathways
C-Myc plays an important role in the cell cycle pathway and apoptosis regulation. Specifically c-Myc is associated with the Wnt signaling pathway which influences cellular proliferation and differentiation. It also interacts with other proteins like Cyclin D1 influencing cell cycle control. These interactions ensure c-Myc's involvement in regulating key processes related to cell proliferation and stability.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
Genes 15: PubMed39457457
2024
Applications
Unspecified application
Species
Unspecified reactive species
American journal of cancer research 13:2188-2200 PubMed37293180
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 24: PubMed36613820
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cancer therapeutics 21:1524-1534 PubMed35877475
2022
Applications
Unspecified application
Species
Unspecified reactive species
RNA (New York, N.Y.) 27:1577-1588 PubMed34535544
2021
Applications
Unspecified application
Species
Unspecified reactive species
Developmental cell 56:1989-2006.e6 PubMed34118203
2021
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 9:8006 PubMed31142756
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com